SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Listed Funds Trust - Roundhill Magnificent Seven ETF

Roundhill Magnificent Seven ETF

The Roundhill Magnificent Seven ETF is currently seeing heightened investor focus as the market closely monitors mega-cap tech performance against broader economic data and valuation concerns. Community discussion is heavily divided between those viewing the basket as a resilient 'flight to safety' amid market volatility and those warning that significant capital concentration in these names may signal an AI-driven valuation bubble.

Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.

Zura Bio Ltd - Ordinary Shares - Class A

Zura Bio is seeing increased trading activity following a public offering of Class A Ordinary Shares that has tightened supply and stabilized its price action. Investors are closely monitoring the stock for a potential momentum push as they look past the recent dilution toward upcoming Phase 2 clinical trial readouts for its lead autoimmune drug, Tibulizumab.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors debate a proposed major executive compensation package, with community sentiment deeply divided between calls for a proxy management vote and optimism regarding potential future M&A activity. The discussion is further fueled by persistent technical debates over short interest data, long-term share accumulation strategies, and technical analysis of the stock's recent price consolidation.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is facing significant market pressure as investors digest conservative long-term revenue guidance and the looming expiration of the TDAPA reimbursement period, despite ongoing share buybacks and institutional accumulation. The community is sharply divided, with some actively debating the long-term potential of the DefenCath product line and Rezzayo clinical trial results, while others express frustration over management's communication and the stock's persistent volatility.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is seeing intense investor focus as rising geopolitical tensions in the Middle East and concerns over European natural gas supply drive demand for energy-related plays. Traders are closely monitoring a potential short squeeze, citing an extremely high cost to borrow and a limited float, while the community actively debates whether the stock's recent momentum will lead to a breakout into double digits.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc is facing significant market skepticism as investors react to weak organic revenue growth and cooling interest in the quantum sector, leading to ongoing bearish sentiment in the community. While some traders are actively shorting the stock, others are debating whether current valuation levels near cash-on-hand represent a potential entry point for long-term holding.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is currently a focal point for momentum traders as geopolitical instability in the Middle East fuels speculation of a significant oil supply disruption. The community is actively debating the stock's high short interest and the potential for a volatile squeeze, with many retail investors focusing on the company's valuation relative to climbing crude prices while others express caution regarding insider activity.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The SPDR S&P 500 ETF Trust is currently trending as investors navigate a complex mix of geopolitical volatility in the Middle East and ongoing debates over market manipulation via high-profile social media commentary. Market participants are intensely focused on the impact of potential trade route disruptions on energy prices while actively discussing whether recent price action represents a genuine support level or merely a bull trap ahead of further volatility.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is trending as investors weigh its potential as an AI infrastructure and data play against recent volatility and legal headwinds, with active community debate focused on the impact of future licensing deals and platform monetization. Traders are closely monitoring heavy options activity and short interest levels, speculating that upcoming legal developments regarding data scraping could trigger significant price swings.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending following a massive fourth-quarter earnings beat, where revenue growth and a shift to profitability fueled significant investor optimism. The community is buzzing with speculation about a potential buyout as the company clears its balance sheet, while simultaneously tracking key catalysts like pending EU regulatory decisions and patent extensions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hudson Bay Capital Management LP Raises Stake in Viridian Therapeutics, Inc. $VRDN

Hudson Bay Capital Management LP raised its stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 46.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 175,251 shares of the company's...

This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know

Key PointsKynam Capital sold 2,957,386 shares of Viridian Therapeutics in the fourth quarter; the estimated trade size was $81.11 million based on quarterly average pricing...

Commodore Capital LP Cuts Stake in Viridian Therapeutics, Inc. $VRDN

Commodore Capital LP reduced its holdings in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 34.4% during the third quarter, according to its most recent disclosure with the...

Viridian Therapeutics, Inc. $VRDN Stock Holdings Reduced by Rosalind Advisors Inc.

Rosalind Advisors Inc. lowered its position in Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 14.3% during the third quarter, according to its most recent Form 13F filing with the SEC...

Wedbush Reaffirms Outperform Rating for Viridian Therapeutics (NASDAQ:VRDN)

Wedbush reissued an "outperform" rating and issued a $44.00 price target on shares of Viridian Therapeutics in a research report on Wednesday...

Viridian Therapeutics (NASDAQ:VRDN) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen downgraded shares of Viridian Therapeutics from a "hold" rating to a "sell" rating in a report on Saturday...

Propel Bio Management LLC Makes New Investment in Viridian Therapeutics, Inc. $VRDN

Propel Bio Management LLC acquired a new stake in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) in the third quarter, according to its most recent filing with the Securities and...

Viridian Therapeutics, Inc. $VRDN Position Increased by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its position in Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 135.6% during the 3rd quarter, according to the company in its most recent disclosure...

Royal Bank Of Canada Has Lowered Expectations for Viridian Therapeutics (NASDAQ:VRDN) Stock Price

Royal Bank Of Canada decreased their target price on shares of Viridian Therapeutics from $45.00 to $42.00 and set an "outperform" rating for the company in a research report on Friday...

Viridian Therapeutics (NASDAQ:VRDN) Releases Earnings Results, Misses Expectations By $0.18 EPS

Viridian Therapeutics (NASDAQ:VRDN - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($1.08) earnings per share for the quarter, missing analysts' consensus...

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$1.08	--	--	N/A
Q4 '25	-$0.98	-$1.08	-10.24%	MISSED
Q3 '25	-$1.02	-$0.34	66.62%	BEAT
Q2 '25	-$1.00	-$1.00	0.09%	BEAT
Q1 '25	-$0.97	-$0.87	10.01%	BEAT

VRDN
Viridian Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest VRDN News

VRDNViridian Therapeutics Inc